APT Medical Inc (688617) - Cash Flow Conversion Efficiency
Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.077x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥233.16 Million ≈ $34.12 Million USD) by net assets (CN¥3.04 Billion ≈ $444.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
APT Medical Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688617 total liabilities for a breakdown of total debt and financial obligations.
APT Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Axos Financial Inc
NYSE:AX
|
0.042x |
|
BRF S.A
F:P5Y
|
0.142x |
|
China International Marine Containers (Group) Co. Ltd
F:OCM
|
0.009x |
|
GS Holdings
KO:078930
|
0.029x |
|
Bancolombia S.A
F:BXK
|
0.267x |
|
Farsoon Technology Co. Ltd. A
SHG:688433
|
N/A |
|
Celcuity LLC
NASDAQ:CELC
|
-0.383x |
|
Choice Hotels International Inc
NYSE:CHH
|
0.473x |
Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is APT Medical Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.55 Billion ≈ $373.85 Million |
CN¥743.39 Million ≈ $108.78 Million |
0.291x | -17.15% |
| 2023-12-31 | CN¥1.96 Billion ≈ $287.10 Million |
CN¥689.06 Million ≈ $100.83 Million |
0.351x | +71.18% |
| 2022-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥367.46 Million ≈ $53.77 Million |
0.205x | +102.58% |
| 2021-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
CN¥181.39 Million ≈ $26.54 Million |
0.101x | -69.25% |
| 2020-12-31 | CN¥450.09 Million ≈ $65.86 Million |
CN¥148.24 Million ≈ $21.69 Million |
0.329x | +107.52% |
| 2019-12-31 | CN¥345.90 Million ≈ $50.62 Million |
CN¥54.90 Million ≈ $8.03 Million |
0.159x | +130.60% |
| 2018-12-31 | CN¥270.70 Million ≈ $39.61 Million |
CN¥18.63 Million ≈ $2.73 Million |
0.069x | +14.29% |
| 2017-12-31 | CN¥214.43 Million ≈ $31.38 Million |
CN¥12.91 Million ≈ $1.89 Million |
0.060x | -- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and acces… Read more